ANALYSIS: As Vital Healthcare revives a restructuring scheme, directors of its external manager seem particularly antsy about their independence.
A family link to a KiwiSaver provider was properly managed, it says, but where was the disclosure?
We won't see rocket emojis on social media for Vulcan, but that's no bad thing.
The cryptocurrency has become a vehicle for naïve speculation and fund management fees.
ANALYSIS: The property company blamed it on Evergrande, but the market says otherwise.
ANALYSIS: Lack of transparency contributes to questionable value for companies raising capital.
ANALYSIS: If an Auckland defence has private backers, what else could be financed that way?
ANALYSIS: Could an acquisition approach underlie the biotech's ASX listing awkwardness?
The accounting profession should be deeply uncomfortable with the latest twist in the PVL saga.
Economics could be the answer to dysfunctional regulation.
